Ergoteles LLC Catalyst Biosciences, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$0.19 - $0.64 $9,559 - $32,200	50,314 New	50,314 $10,000
Q4 2021 Feb 14, 2022	SELL	$0.91 - $4.16 $95,742 - $437,677	-105,211 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.78 - $5.18 $12,432 - $17,037	-3,289 Reduced 3.03%	105,211 $432,000
Q2 2021 Aug 12, 2021	BUY	$4.1 - $5.33 $444,849 - $578,305	108,500 New	108,500 $470,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.